By Charles Grob — 1996
On November 26, 1996, Charles Grob, M.D. visited with Albert Hofmann in Rheinfelden, outside of Basel, Switzerland, where Dr. Hofmann was recovering from knee surgery. The following are excerpts from their conversation.
Read on maps.org
CLEAR ALL
Roland Griffiths' psilocybin experiments have produced striking evidence for therapeutic uses of hallucinogens.
1
A new generation of research into psilocybin could change how we treat numerous mental health conditions.
In a survey of thousands of people who reported having experienced personal encounters with God, researchers report that more than two-thirds of self-identified atheists shed that label after their encounter, regardless of whether it was spontaneous or while taking a psychedelic.
Scientists Roland Griffiths and Matthew Johnson sit down with journalist Anderson Cooper to discuss the promise of psychedelics as a form of treatment for anxiety, depression, addiction, and more.
Roland Griffiths is a Johns Hopkins University professor, researcher and expert in the field of pharmacology. He is best known for his research into the beneficial effects psilocybin on cancer patients.
We spoke about his research with psilocybin, his interest in spiritual experiences, and how psychedelics may provide help for people who are dying.
As I travel around the globe speaking and training, I have consistently found that most people ask me the same question, “How do I discover my purpose in life?”
2
Near-death experiences (NDEs) are complex subjective experiences, which have been previously associated with the psychedelic experience and more specifically with the experience induced by the potent serotonergic, N,N-Dimethyltryptamine (DMT).
The scientist talks to Laurence Phelan about fighting the establishment, battling preconceptions and breaking down egos.
In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.